Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-067548
Filing Date
2026-06-11
Accepted
2026-06-11 07:02:02
Documents
2
Period of Report
2026-06-11

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0294281-6k_purple.htm 6-K 13252
2 PURPLE BIOTECH PRESENTS NEW PRECLINICAL DATA AT EACR 2026 HIGHLIGHTING IM1240'S ea029428101ex99-1.htm EX-99.1 27323
  Complete submission text file 0001213900-26-067548.txt   41845
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 261081421
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)